Currently, the five-year survival rate for Pancreatic Cancer sufferers is still just 8.8%.
By comparison, the five-year survival rate for sufferers of Breast Cancer is 90%, and Prostate Cancer, 95%.
The difference is research funding.
Despite being one of the most lethal cancers, Pancreatic Cancer receives only a fraction of a funding of other top five cancers - with direct funding of only $5m over 2009-2011.
The leaps forward in survival rates for Prostate and Breast cancers are due to direct funding of $42m and $86m over the same period.
The Avner Pancreatic Cancer Foundation was established to change these statistics. We are the only charity in Australia exclusively dedicated to the disease.
We allocate research funds via an Advisory Panel of globally recognised experts, and since launching our Grants Program in 2015, $5.8m of grant funding has been allocated by the Foundation. With a further $400,000 allocated in November 2018.
This will bring the number of grants that we have made for innovative Australian research projects to 22 in total. This is the largest contribution towards Pancreatic Cancer research from a non-government organisation.
Our contribution has been described by a leading expert as “The most significant funding for Pancreatic Cancer research in Australia in recent times.”